ArticleFrontiers in medicine2026
Evidence of West Nile virus exposure in healthy donors and a clinical case in an immunocompromised child: emerging public health implications.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: West Nile virus (WNV), an emerging mosquito-borne flavivirus, is a growing global concern, particularly in tropical regions, where climatic conditions favor vector proliferation. Although often asymptomatic, less than 1% of cases develop severe neuroinvasive disease, primarily among the elderly or immunocompromised. Transfusion-transmitted WNV infections have been documented but remain underrecognized in the Middle East. Methods: This study reports a case of a 4-year-old Saudi girl with Ewing's sarcoma undergoing chemotherapy who developed WNV encephalitis following multiple blood transfusions from 30 healthy blood donors. The investigation was conducted at a tertiary hospital in Jeddah. Serological screening of 30 blood donors was performed to identify potential sources of infection. Results: The patient presented with febrile seizures, and MRI findings of bilateral thalamic and midbrain signal changes were consistent with viral encephalitis. WNV infection in the patient was confirmed by the polymerase chain reaction. The clinical picture correlated with reported cases of transfusion-associated WNV infection in immunocompromised hosts. Four of the 30 donor samples (13.3%) tested positive for anti-WNV antibodies, indicating prior exposure among donors and supporting transfusion as a plausible but unconfirmed transmission route, as retrospective molecular testing of implicated blood units was not available. Conclusion: This case underscores the need to consider the incorporation of nucleic acid testing (NAT) for WNV RNA into pretransfusion screening protocols, particularly for high-risk recipients and during peak transmission periods, to reduce the risk of transfusion-transmitted infection. The detection of anti-WNV antibodies among healthy donors highlights the silent viral circulation in the community. Strengthening national surveillance systems, enhancing vector control measures, and improving clinician awareness are vital to mitigate transfusion-related WNV transmission in endemic and emerging regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.